Skip to main content

Table 3 Clinical data variance over time

From: Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study

Variable Mean ± SD (Range)

Insulin (n = 8)

Sulfonylurea (n = 5)

Metformin (n = 6)

Thiazoli-dinediones (n = 6)

P Value

ALT (U/L) Change/Yr

1.8 ± 3.0 (-2.0 – 7.8)

4.7 ± 8.6 (-2.5 – 19.0)

-2.8 ± 22.0 (-41.5 – 26.5)

-1.1 ± 7.7 (-11.0 – 9.5) (n = 5)

0.757

FEV1 (%) Change/Yr

-0.3 ± 3.3 (-3.9 – 6.3)

1.4 ± 9.6 (-9.0 – 13.0)

-1.2 ± 3.2 (-7.0 – 1.5)

5.2 ± 7.8 (-2.5 – 20.0)

0.422

Weight (kg) Change/Yr

1.5 ± 2.2 (-1.2 – 6.3)

0.5 ± 2.2 (-2.4 – 2.7)

1.8 ± 3.9 (-3.3 – 8.5)

4.3 ± 6.0 (0.3 – 16.0)

0.384

HbA1c Change/Yr

-0.3 ± 0.2 (-0.5 – 0.1)

-0.8 ± 0.7 (-1.8 – -0.1)

-1.1 ± 1.4 (-3.2 – 0.6)

-0.6 ± 1.3 (-3.2 – 0.5)

0.283

  1. SD, standard deviation; Yr, year; ALT, alanine aminotransferase; FEV1, forced expiratory volume at 1 second; HbA1c, percent glycosylated hemoglobin. P values for ALT and Weight are from one-way analysis of variance (ANOVA); P values for FEV1 and HbA1c are from Welch ANOVA for unequal group variances.